Erik Won

New Capabilities

Presented the trial figures in the October 2026 announcement

The FDA cleared Wave Neuroscience's personalized magnetic brain therapy for PTSD on June 3, 2026. The clinical summary filed with the decision, K260402, reports that 68.2% of treated patients were in remission two to four months after treatment.

Updated Oct 27